Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

l, 1-[1,4-phenylenebis (methylene)]-bis-1,4,8,11- tetraazacyclotetradecane

EU orphan designation number: EU/3/04/227   
Active ingredient: l, 1´-[1,4-phenylenebis (methylene)]-bis-1,4,8,11- tetraazacyclotetradecane
Indication: Treatment to mobilize progenitor cells prior to stem cell transplantation
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Mozobil on 31/07/2009 with the number EU/1/09/537

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Orphan Designation EMEA/OD/045/04 (2004)4193 of 20/10/2004
25/06/2007 Transfer of orphan designation EMEA/OD/045/04/T/01 (2007)3141 of 21/06/2007